arXiv · 2608.15969
Doubly robust estimation of while-alive estimands in individually-randomized and cluster-randomized trials
Abstract
Randomized trials in chronic disease settings often measure treatment benefit through recurrent non-fatal events that are truncated by death, where conventional summaries either discard recurrences, conflate the treatment effect with survival, or treat death as censoring and forfeit a causal interpretation. While-alive estimands measure event burden per unit time alive, but doubly robust estimation for the exposure-weighted while-alive rate remains undeveloped, particularly in cluster-randomized trials (CRTs). We develop a doubly robust estimator based on a local Nelson-Aalen representation, with augmented estimating equations targeting the marginal hazard of the terminal event and the weighted recurrent event rate among those alive; the estimator accommodates multiple event types through prespecified clinical weights and remains consistent if either the censoring model or the outcome working models are correctly specified. For CRTs, we define a new pair of individual-average and cluster-average estimands under informative cluster size, with inference based on cluster-level influence functions. We establish component-wise double robustness and asymptotic normality, corroborate the theory in simulations, and illustrate the methods with reanalyses of data from two completed randomized trials.
Explore related subjects
Keep this discovery
Xi Fang, Da Zhao, Fan Li. 2026-08-16. Doubly robust estimation of while-alive estimands in individually-randomized and cluster-randomized trials. https://arxiv.org/abs/2608.15969
Cite the original work for its findings. Save a collection to share your selection of sources.